CSL Limited
CSL
Κατάταξη σε μετοχές
#362
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Τιμή μετοχής
$138.58
Κεφαλαιοποίηση
$66.50B
Αλλαγή (1 ημέρα)
0.72%
Αλλαγή (1 έτος)
-2.29%
Χώρα
AU
Εμπόριο CSL Limited (CSL)
Κατηγορία
Healthcare
Ιστορικό μερισματικής απόδοσης για CSL Limited (CSL)
Η μερισματική απόδοση (TTM) της CSL Limited (σύμβολο μετοχής: CSL) στις 2024-06-30 ήταν: 1.35%
Μέση μερισματική απόδοση τα τελευταία 5 χρόνια: 1.54%
Μέση μερισματική απόδοση τα τελευταία 5 χρόνια: 1.54%
Ιστορικό μερισματικής απόδοσης για CSL Limited (CSL) από 2000 έως 2026
Μερισματική απόδοση στο τέλος κάθε έτους (TTM)
| Έτος | Μερισματική απόδοση | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 2.17% | 15.43% |
| 2025 | 1.88% | 39.26% |
| 2024 | 1.35% | -25.41% |
| 2023 | 1.81% | 9.70% |
| 2022 | 1.65% | 66.67% |
| 2021 | 0.99% | 41.43% |
| 2020 | 0.70% | -39.13% |
| 2019 | 1.15% | 16.16% |
| 2018 | 0.99% | 2.06% |
| 2017 | 0.97% | -37.01% |
| 2016 | 1.54% | 18.46% |
| 2015 | 1.30% | -14.47% |
| 2014 | 1.52% | -7.88% |
| 2013 | 1.65% | -21.05% |
| 2012 | 2.09% | -19.62% |
| 2011 | 2.60% | 31.31% |
| 2010 | 1.98% | 47.76% |
| 2009 | 1.34% | 26.42% |
| 2008 | 1.06% | 23.26% |
| 2007 | 0.86% | -8.51% |
| 2006 | 0.94% | 28.77% |
| 2005 | 0.73% | 65.91% |
| 2004 | 0.44% | -76.84% |
| 2003 | 1.90% | 533.33% |
| 2002 | 0.30% | 15.38% |
| 2001 | 0.26% | -35.00% |
| 2000 | 0.40% | 0.00% |
Μερισματικές αποδόσεις (TTM) για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Μερισματική απόδοση | Χώρα |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
|
| 0.72% |
BE
|
